Russell P. Elliott, VP Drug Development at Foamix Pharmaceuticals Ltd. (FOMX), sold 142 shares at $5.08 ($721) on 2018-04-02, disclosed to the SEC on 2018-04-04.
Open-market sale of $721 FOMX by VP Drug Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| FOMX | SELL | 2018-03-06 | $5K | — | Filing → |